Go offline with the Player FM app!
🫀 Foxglove, Frailty, and HFrEF — Digitoxin in Advanced Heart Failure
Manage episode 503362835 series 2740117
🚨 New RCT Alert from the NEJM!
Can an old 💊 make a comeback in modern 💓 failure care?
📌 The DIGIT-HF trial showed that digitoxin, a cardiac glycoside with hepatic clearance, reduced the combined endpoint of all-cause death or HF hospitalization in HFrEF patients on contemporary guideline-directed therapy — including ARNI, beta-blockers, MRAs & SGLT2i.
🩺 HR = 0.82; p = 0.03 📉
👩⚕️ Safe in CKD, consistent benefit in women.
⚠️ Serious AEs slightly higher (4.7% vs 2.8%)
📥 NNT = 22.
💡Is it time to reconsider digitoxin in advanced HFrEF?
#CardioTwitter #HFrEF #HeartFailure #Digitoxin #NEJM #Cardiology #SGLT2i #GuidelineTherapy
673 episodes
Manage episode 503362835 series 2740117
🚨 New RCT Alert from the NEJM!
Can an old 💊 make a comeback in modern 💓 failure care?
📌 The DIGIT-HF trial showed that digitoxin, a cardiac glycoside with hepatic clearance, reduced the combined endpoint of all-cause death or HF hospitalization in HFrEF patients on contemporary guideline-directed therapy — including ARNI, beta-blockers, MRAs & SGLT2i.
🩺 HR = 0.82; p = 0.03 📉
👩⚕️ Safe in CKD, consistent benefit in women.
⚠️ Serious AEs slightly higher (4.7% vs 2.8%)
📥 NNT = 22.
💡Is it time to reconsider digitoxin in advanced HFrEF?
#CardioTwitter #HFrEF #HeartFailure #Digitoxin #NEJM #Cardiology #SGLT2i #GuidelineTherapy
673 episodes
Minden epizód
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.